![OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud](https://www.g2intelligence.com/wp-content/uploads/2023/06/July.NLR_.OIGSemiAnnualReport-iStock-1100x800-1-1080x675.jpg)
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Current genetic testing enforcement trends and what you can do to minimize the liability risks of your lab.
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
A written policy helps establish your right to do excluded persons checks and take appropriate actions if they come back positive.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.